Substituted imidazoles as GLP-1 receptor agonists
US11584751B1 · kind B1 · utility
5Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2021 |
| Grant date | Feb 21, 2023 |
| Priority date | — |
| Expiry date | Jan 8, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of GLP-1 receptor, a pharmaceutical composition comprising a compound of Formula (I), and a method of treating or preventing a disease in which GLP-1 receptor plays a role.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.